The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Open accessAbstract
Radiotherapy plays a central part in curing cancer. For decades, most research on improving treatment outcomes has focused on modulating radiation-induced biological effects on cancer cells. Recently, we have better understood that components within the tumour microenvironment have pivotal roles in determining treatment outcomes. In this Review, we describe vascular, stromal and immunological changes that are induced in the tumour microenvironment by irradiation and discuss how these changes may promote radioresistance and tumour recurrence. We also highlight how this knowledge is guiding the development of new treatment paradigms in which biologically targeted agents will be combined with radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Generation of intratumoral O2 is also feasible to improve the efficacy of radiotherapy by using bioactive albumin-MnO2 nanoparticles [94].”
From Hypoxia Signaling in Cancer: From Basics to Clinical Practice (2021) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedMMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells
Badiga, A. V., Chetty, C., Kesanakurti, D., Are, D., Gujrati, M., Klopfenstein, J. D., Dinh, D. H., & Rao, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020614 · Cited by 110
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,005
Xiang, H., Wu, Y., Zhu, X., She, M., An, Q., Zhou, R., Xu, P., Zhao, F., Yan, L., & Zhao, Y. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03303 · Cited by 83
Research progress on tumor hypoxia-associative nanomedicine
Xu, X., Chen, S., Yi, N.-B., Li, X., Chen, S., Lei, Z., Cheng, D., & Sun, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.003 · Cited by 86
Gu, H., Huang, T., Shen, Y., Liu, Y., Zhou, F., Jin, Y., Sattar, H., & Wei, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5801209 · Cited by 82
“In addition, some studies confirm that tumor-infiltrating lymphocyte (TIL) can be attracted by ROS and exert their antitumor effects [14].”
BackgroundNanoparticles Targeting STATs in Cancer Therapy
Ashrafizadeh, M., Ahmadi, Z., Kotla, N. G., Afshar, E. G., Samarghandian, S., Mandegary, A., Pardakhty, A., Mohammadinejad, R., & Sethi, G. (2019) · Cells · doi:10.3390/cells8101158 · Cited by 83
“However, metastasis and subsequent recurrence are the most challenging problems in cancer therapy [5,6].”
BackgroundFunctional Immune Cell‐Derived Exosomes Engineered for the Trilogy of Radiotherapy Sensitization
Ma, X., Yao, M., Gao, Y., Yue, Y., Li, Y., Zhang, T., Nie, G., Zhao, X., & Liang, X. (2022) · Advanced Science · doi:10.1002/advs.202106031 · Cited by 82
Liu, H., Cheng, R., Dong, X., Zhu, S., Zhou, R., Yan, L., Zhang, C., Wang, Q., Gu, Z., & Zhao, Y. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b03280 · Cited by 83
TGF-beta signaling in cancer radiotherapy
Wang, J., Xu, Z., Wang, Z., Du, G., & Lun, L. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155709 · Cited by 87
Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity
Cui, M., Xiao, H., Luo, D., Zhang, X., Zhao, S., Zheng, Q., Li, Y., Zhao, Y., Dong, J., Li, H., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111786 · Cited by 82
“with cancer receive radiotherapy at some point in the course of their disease [5]; meanwhile, radiation exposure in a mass casualty setting is a serious military and public health concern [6].”
BackgroundLi, D., Qu, C., Ning, Z., Wang, H., Zang, K., Zhuang, L., Chen, L., Wang, P., & Meng, Z. (2016) · PubMed Central · Cited by 81
Deng, X., Guan, W., Qing, X., Yang, W., Que, Y., Tan, L., Liang, H., Zhang, Z., Wang, B., Liu, X., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b19148 · Cited by 82
B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells
Lu, H., Shi, T., Wang, M., Li, X., Gu, Y., Zhang, X., Zhang, G., & Chen, W. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1748991 · Cited by 82
“However, the risk of recurrence and resistance to radiotherapy or chemotherapy results in poor clinical outcomes.(7,8) New therapeutic methods have been proposed for colon cancer treatment, such as targeted therapy and immunotherapy.”
BackgroundZhao, X., & Shao, C. (2020) · Cancers · doi:10.3390/cancers12102762 · Cited by 86
“When combined with ICB, the above effect seems to be more intense [88].”
Yang, Y., Chong, Y., Chen, M., Dai, W., Zhou, X., Ji, Y., Qiu, G., & Du, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02825-2 · Cited by 82
“Many factors might be involved in the poor response to radiotherapy, including hypoxia, cancer stem cell phenotype, cell cycle redistribution and activated DNA repair ability [26, 27].”
BackgroundTargeting tumor vascularization: promising strategies for vascular normalization
Zheng, R., Li, F., Li, F., & Gong, A. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03701-8 · Cited by 84
Tao, Y., Zhu, L., Zhao, Y., Yi, X., Zhu, L., Ge, F., Mou, X., Chen, L., Sun, L., & Yang, K. (2018) · Nanoscale · doi:10.1039/c7nr08747k · Cited by 82
West, M. A., Astin, R., Moyses, H. E., Cave, J., White, D., Levett, D. Z. H., Bates, A. S., Brown, G. M., Grocott, M. P. W., & Jack, S. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1566775 · Cited by 80
“system against cancer cells via immunogenic cell death [42]; exercise may potentiate this effect leading to greater tumor regression.”
BackgroundTrommer, M., Yeo, S. Y., ten Persigehl, T., Bunck, A., Grüll, H., Schlaak, M. S., Theurich, S., von Bergwelt‐Baildon, M., Morgenthaler, J., Herter, J. M., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00511 · Cited by 80
“Local RT is considered to induce immunogenic cell death (ICD) associated with antigen release, cytokine production, and complement activation, leading to immune responses, and to a tumor vaccination (Formenti and Demaria, 2012; Frey et al., 2014; Barker et al., 2015).”
BackgroundUnderstanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers
Kielbassa-Elkadi, K., Vegna, S., Ramirez, C. F. A., & Akkari, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02215 · Cited by 82
Ni, J., Zhang, Z., Ge, M.-J., Chen, J., & Zhuo, W. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00953-z · Cited by 85
“In addition to myelosuppression and peripheral blood loss, radiotherapy upregulates the expression of negative immune checkpoint ligands such as PD-L1, which may enhance the susceptibility of tumor cells to ICIs [91, 92].”
BackgroundManukian, G., Bar‐Ad, V., Lü, B., Argiris, A. E., & Johnson, J. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00122 · Cited by 83
Exosomes in Cancer Radioresistance
Ni, J., Bucci, J. A., Malouf, D. J., Knox, M. C., Graham, P., & Li, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00869 · Cited by 79
“It was reported radioresistance is highly associated with tumor microenvironment (8, 9).”
BackgroundEffects of Radiation on the Tumor Microenvironment
Monjazeb, A. M., Schalper, K. A., Villarroel‐Espíndola, F., Nguyen, A. T., Shiao, S. L., & Young, K. H. (2020) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.12.004 · Cited by 87
Cui, Y., Li, B., Pollom, E. L., Horst, K. C., & Li, R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0825 · Cited by 80
“Although tumor intrinsic radiosensitivity is widely accepted for its direct impact on radiation response, various factors in the tumor microenvironment also influence andmodulate therapeutic effects (17).”
BackgroundProteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models
Blanco‐Fernandez, B., Gaspar, V. M., Engel, E., & Mano, J. F. (2021) · Advanced Science · doi:10.1002/advs.202003129 · Cited by 78
Zhang, Y., Sriramaneni, R. N., Clark, P. A., Jagodinsky, J. C., Ye, M., Jin, W. J., Wang, Y., Bates, A. M., Kerr, C. P., Le, T. Q. H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32645-x · Cited by 80
Shi, Y., Guo, Z., Fu, Q., Shen, X., Zhang, Z., Sun, W., Wang, J., Sun, J., Zhang, Z., Liu, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37253-x · Cited by 78
“18A, Supplementary Table 10).”
InfluentialTargeting invadopodia for blocking breast cancer metastasis
Meirson, T., & Gil-Henn, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.05.002 · Cited by 80
Salmonella -Mediated Cancer Therapy: An Innovative Therapeutic Strategy
Mi, Z., Feng, Z., Li, C., Yang, X. H., Ma, M., & Rong, P. (2019) · Journal of Cancer · doi:10.7150/jca.32650 · Cited by 83
“In addition, cell stroma and immune modulation also play important roles in radiotherapy resistance [4].”
BackgroundZhang, Y., Liu, X., Zeng, L., Zhao, X., Chen, Q., Pan, Y., Bai, Y., Shao, C., & Zhang, J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01956-7 · Cited by 81
“It can alter the expression of pro-survival genes and then mediate cell–cell interaction through extracellular environmental factors [7, 8].”
BackgroundWang, G., Li, B., Tian, H., Xie, L., Yan, J., Sang, W., Li, J., Zhang, Z., Li, W., & Dai, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202213425 · Cited by 80
Rodriguez-Ruiz, M. E., Garasa, S., Rodríguez, I., Solórzano, J. L., Barbés, B., Yanguas, A., Teijeira, Á., Etxeberría, I., Aristu, J., Halin, C., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.10.043 · Cited by 77
Zhong, D., Li, W., Hua, S., Qi, Y., Xie, T., Qiao, Y., & Zhou, M. (2021) · Theranostics · doi:10.7150/thno.55441 · Cited by 76
“Unfortunately, the hypoxia condition that exists in primary solid tumors leads to the radioresistance of tumor cells, greatly reducing the therapeutic efficiency and further increasing the risk of damage to normal tissue caused by the high dosage of irradiation [8-11].”
BackgroundAntonioli, L., Novitskiy, S. V., Sachsenmeier, K. F., Fornai, M., Blandizzi, C., & Haskó, G. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.005 · Cited by 77
Kim, J., & Lee, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091854 · Cited by 80
“As hypoxia is believed to be one of main drivers of radiotherapy resistance [79], it is reasonable to mention that targeting c-Met could be an attractive way to inhibit tumor progression as well as to overcome radiotherapy resistance.”
BackgroundComplex interplay between tumor microenvironment and cancer therapy
Shen, M., & Kang, Y. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0663-7 · Cited by 76
He, C., Zhang, X., Yan, R., Zhao, P., Chen, Y., Li, M., Chen, C., Fan, T., Lu, Y., Wang, C., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00797k · Cited by 75
Ionizing radiation effects on the tumor microenvironment
Portella, L., & Scala, S. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.07.003 · Cited by 78
Wu, Y., Yao Zong, Y. U. A. N., Zhang, J., Gui, H., Liu, J., & Liu, J. (2022) · Advanced Science · doi:10.1002/advs.202200681 · Cited by 75
Zhou, G. (2020) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2020.02.002 · Cited by 76
BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair
Ni, M., Li, J., Zhao, H., Xu, F., Cheng, J., Yu, M., Ke, G., & Wu, X. (2021) · Oncogene · doi:10.1038/s41388-021-01735-3 · Cited by 73
Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy
Xu, X., Wu, Y., Qian, X., Wang, Y., Wang, J., Li, J., Li, Y., & Zhang, Z. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101428 · Cited by 75
Pterostilbene: Mechanisms of its action as oncostatic agent in cell models and in vivo studies
Ma, Z., Zhang, X., Xu, L., Liu, D., Di, S., Li, W., Zhang, J., Zhang, H., Li, X., Han, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104265 · Cited by 75
Mills, B. N., Qiu, H., Drage, M. G., Chen, C., Mathew, J. S., Garrett-Larsen, J., Ye, J., Uccello, T. P., Murphy, J. D., Belt, B. A., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2495 · Cited by 75
“PDAC vasculature remains unchanged following SBRT Proliferative endothelial cells (EC) in the TME can display radiosensitivity (37).”
BackgroundPure Organic AIE Nanoscintillator for X‐ray Mediated Type I and Type II Photodynamic Therapy
Yu, Y., Xiang, L., Zhang, X., Zhang, L., Ni, Z., Zhu, Z., Liu, Y., Lan, J., Liu, W., Xie, G., et al. (2023) · Advanced Science · doi:10.1002/advs.202302395 · Cited by 73
Shen, M., Xu, L. J., Li, Y., Tsai, Y., Keng, P. C., Chen, Y., Lee, S. O., & Chen, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19193 · Cited by 73
“[52], radiation effects on TME was a complex reaction, so it might be hard to conclude that radiation effect was immunostimulatory”
BackgroundClinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
Oladejo, M., Paterson, Y. Y. W., & Wood, L. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642316 · Cited by 74
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
Liu, D., Che, X., Wang, X., Ma, C., & Wu, G. (2023) · Pharmaceuticals · doi:10.3390/ph16101384 · Cited by 84
“Concurrently, radiotherapy damages the tumor vasculature, increasing its permeability due to direct effects on endothelial cells and the upregulated release of VEGF from irradiated tumor cells [215,216].”
BackgroundChen, H., Luan, X., Paholak, H. J., Burnett, J., Stevers, N. O., Sansanaphongpricha, K., He, M., Chang, A. E., Li, Q., & Sun, D. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0190 · Cited by 71
Advances in engineering local drug delivery systems for cancer immunotherapy
Abdou, P., Wang, Z., Chen, Q., Chan, A., Zhou, D. R., Gunadhi, V., & Gu, Z. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1632 · Cited by 72
Knitz, M. W., Bickett, T. E., Darragh, L. B., Oweida, A. J., Bhatia, S., Court, B. V., Bhuvane, S., Piper, M., Gadwa, J., Mueller, A. C., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001955 · Cited by 71
Feng, Z., Zhang, Y., Yang, C., Liu, X., Huangfu, Y., Zhang, C., Huang, P., Dong, A., Liu, J., Liu, J., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201671 · Cited by 71
Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment
Raaijmakers, K., Adema, G. J., Bussink, J., & Ansems, M. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03251-0 · Cited by 78
Zhang, Y., Jiang, X., Zhang, N., Chen, M., Wang, H., & Zhu, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.017 · Cited by 69
Pei, P., Zhang, Y., Jiang, Y., Shen, W., Chen, H., Yang, S., Zhang, Y., Yi, X., & Yang, K. (2022) · ACS Nano · doi:10.1021/acsnano.2c04982 · Cited by 71
The abscopal effect in patients with cancer receiving immunotherapy
Nelson, B. E., Adashek, J. J., Lin, S. H., & Subbiah, V. (2023) · Med · doi:10.1016/j.medj.2023.02.003 · Cited by 69
Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy
Zeng, Q., Liu, M., Wang, Z., Zhou, R., & Ai, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02366-y · Cited by 90
“Dose-dependent toxicity to healthy tissues and immune system, particularly radi-ation-sensitive CD8 + T cells in lymphoid organs, compromises systemic anti-tumor responses [17].”
Brindle, K. M., Izquierdo-García, J. L., Lewis, D. Y., Mair, R. J., & Wright, A. J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.7636 · Cited by 70
“An attractive application is escalating radiotherapy doses to [(18)F]fluoromisonidazole-positive tumor regions, which are hypoxic and therefore likely to be radioresistant.(84) Studies are under way to determine whether there is any clinical benefit from this approach.”
BackgroundNew insights in the relative radiobiological effectiveness of proton irradiation
Ilicic, K., Combs, S. E., & Schmid, T. E. (2018) · Radiation Oncology · doi:10.1186/s13014-018-0954-9 · Cited by 70
“Background Today, more than 50% of all cancer patients are treated with radiotherapy [1], mostly with high-energy X-rays, which are produced by linear accelerators [2].”
BackgroundMeng, L., Cheng, Y., Gan, S., Zhang, Z., Tong, X., Xu, L., Jiang, X., Zhu, Y., Wu, J., Yuan, A., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00808 · Cited by 69
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance
Zheng, W., Skowron, K. B., Namm, J. P., Burnette, B., Fernandez, C., Arina, A., Liang, H. L., Spiotto, M. T., Posner, M. C., Fu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9915 · Cited by 69
“IR regulates several processes of the immune response, including production of inflammatory cytokines/chemokines, antigen exposure and presentation, T cell priming, as well as regulation of immune-suppressive cells and factors [9, 10].”
BackgroundStereotactic ablative radiotherapy for colorectal cancer liver metastasis
Wang, H., Li, X., Peng, R., Wang, Y., & Wang, J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.018 · Cited by 68
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
Rabah, N., Mohand, F.-E. A., & Kravchenko‐Balasha, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814256 · Cited by 69
“It was shown, for example, that RT can alter the ECM by upregulating integrins, facilitating GBM infiltration [76].”
BackgroundPotentiating prostate cancer immunotherapy with oncolytic viruses
Lee, P. C., & Gujar, S. A. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.10 · Cited by 70
Radiotherapy in Dupuytren’s disease: a systematic review of the evidence
Kadhum, M., Smock, E., Khan, A., & Fleming, A. N. M. (2017) · Journal of Hand Surgery (European Volume) · doi:10.1177/1753193417695996 · Cited by 68
“Radiation fibrosis is a well-characterized late effect of radiotherapy (Barker et al., 2015) and the use of a fibrosis-inducing modality of therapy to treat a fibrosing condition may, perhaps, seem counter-intuitive.”
BackgroundSelf-citationLiao, J., Jin, H., Li, S., Xu, L., Peng, Z., Wei, G., Long, J., Guo, Y., Kuang, M., Zhou, Q., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1419-1 · Cited by 68
Seifert, M., Peitzsch, C., Gorodetska, I., Börner, C., Klink, B., & Dubrovska, A. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007460 · Cited by 68
“Tumor progression and therapy response can be influenced by changes of the tumor microenvironment as a consequence of a radiation therapy [8, 9].”
BackgroundBienkowska, K., Hanley, C. J., & Thomas, G. J. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.686337 · Cited by 71
Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies
Amaldoss, M. J. N., Yang, J., Koshy, P., Unnikrishnan, A., & Sorrell, C. C. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103386 · Cited by 68
Jiang, H., Li, A. M., & Ye, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1004978 · Cited by 69
Hou, Y., Yang, K., Wang, L., Wang, J., Huang, X., Piffkó, A., Luo, S. Z., Yu, X., Rao, E., Martinez, C. N., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3206 · Cited by 71
Moutabian, H., Majdaeen, M., Ghahramani‐Asl, R., Yadollahi, M., Gharepapagh, E., Ataei, G., Falahatpour, Z., Bagheri, H., & Farhood, B. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02561-7 · Cited by 69
Cruz‐Gregorio, A., Martínez-Ramírez, I., Pedraza‐Chaverrí, J., & Lizano, M. (2019) · Cancers · doi:10.3390/cancers11020182 · Cited by 67
“For example, IR induces damage and death of the endothelial cells that surround tumour cells, which increases cytokines and chemokines levels, initiating an inflammatory response [24].”
BackgroundTraditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare
Zhang, R., Gao, X., Bai, H., & Ning, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00538 · Cited by 68
“Because radiotherapy alters the microbiome composition and destroys the intestinal barrier (Barker et al., 2015), pathobionts can easily access the intestinal immune system (Belkaid and Hand, 2014).”
BackgroundRadiotherapy-induced metabolic hallmarks in the tumor microenvironment
Mittal, A., Nenwani, M., Sarangi, I., Achreja, A., Lawrence, T. S., & Nagrath, D. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.05.005 · Cited by 72
Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer
Zhou, T., Zhang, L., He, J., Miao, Z., Li, Y., Zhang, Y., Liu, Z., Zhang, S.-Z., Chen, Y., Zhou, G.-C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133899 · Cited by 74
Wang, S., Zhou, Z., Hu, R., Dong, M., Zhou, X., Ren, S.-Y., Zhang, Y., Chen, C., Huang, R., Zhu, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202207608 · Cited by 66
The cancer cell adhesion resistome: mechanisms, targeting and translational approaches
Dickreuter, E., & Cordes, N. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0326 · Cited by 67
Manoochehri, H., Afshar, S., Pashaki, A. S., Mahdavinezhad, A., Nikzad, S., Najafi, R., Amini, R., Gholami, M. H., Khoshghadam, A., & Saidijam, M. (2017) · Japanese Journal of Radiology · doi:10.1007/s11604-017-0679-y · Cited by 68
Zhu, Y., Wen, L., Shao, S., Tan, Y., Meng, T., Yang, X., Liu, Y., Liu, X., Yuan, H., & Hu, F. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.023 · Cited by 66
Vaughan, E., Machta, J. S., Walker, M., Toumpanakis, C., Caplin, M. E., & Navalkissoor, S. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180041 · Cited by 66
Hybrid nanoparticle composites applied to photodynamic therapy: strategies and applications
Zhang, C., Chen, W., Zhang, T., Jiang, X., & Hu, Y. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00093k · Cited by 65
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 65
“Radiotherapy is known to induce the synthesis of large amounts of ECM proteins, resulting in the survival of cancer cells (Barker et al., 2015; Eke and Cordes, 2011; Erkan et al., 2007).”
Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells
Berg, T. J., & Pietras, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.011 · Cited by 64
Advances in radiotherapy and immunity in hepatocellular carcinoma
Yang, Y., Xiong, L., Li, M., Jiang, P., Wang, J., & Li, C. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04386-y · Cited by 68
“Radiotherapy, as one of the main modalities for the first-line treatment of multiple solid tumours, has a direct and significant impact on the tumour stroma, blood vessels, and immune cells [97].”
BackgroundZheng, K., Song, R., Li, R. F., Liu, M., Ba, Y., Jiang, W., & Fan, K. (2024) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000046 · Cited by 70
Enhancing Ferroptosis-Mediated Radiosensitization via Synergistic Disulfidptosis Induction
Li, Q., Wu, Z., Chen, S., Liang, Y., Zhu, K., Su, N., Liu, T., & Zhao, B. (2024) · ACS Nano · doi:10.1021/acsnano.4c15932 · Cited by 69
Chao, Y., Wang, G., Liang, C., Yi, X., Zhong, X., Liu, J., Gao, M., Yang, K., Cheng, L., & Liu, Z. (2016) · Small · doi:10.1002/smll.201601375 · Cited by 65
Marampon, F., Ciccarelli, C., & ZANI, B. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102530 · Cited by 74
Wanigasooriya, K., Tyler, R., Barros-Silva, J. D., Sinha, Y., Ismail, T., & Beggs, A. D. (2020) · Cancers · doi:10.3390/cancers12051278 · Cited by 65
“Resistance to radiotherapy may be induced by tumour revascularisation and inhibiting cellular hypoxia [14].”
Barbarisi, M., Iaffaioli, R. V., Armenia, E., Schiavo, L., Sena, G. D., Tafuto, S., Barbarisi, A., & Quagliariello, V. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26238 · Cited by 69
Seo, I., Lee, H. W., Byun, S. J., Park, J. Y., Min, H., Lee, S. H., Lee, J., Kim, S., & Bae, S. U. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001610 · Cited by 65
Lighting up the tumor fire with low-dose irradiation
Herrera, F. G., Romero, P. J., & Coukos, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.01.006 · Cited by 68
DNA-Based MXFs to Enhance Radiotherapy and Stimulate Robust Antitumor Immune Responses
Yang, Y. P., Liu, B., Liu, Y., Chen, J., Sun, Y., Pan, X., Xu, J., Xu, S., Liu, Z., & Tan, W. (2022) · Nano Letters · doi:10.1021/acs.nanolett.1c04888 · Cited by 65
Zhao, J., Chen, Y., Xiong, T., Han, S., Li, C., He, Y., He, Y., Zhao, G., Wang, T., Wang, L., et al. (2023) · Small · doi:10.1002/smll.202206415 · Cited by 62
Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours
Fu, Q., Zhang, S., Shen, S., Gu, Z., Chen, J., Song, D., Sun, P., Wang, C., Guo, Z., Gao, Y. Q., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01239-x · Cited by 63
“Modern radiotherapy techniques can precisely irradiate tumours and deliver high-dose radiation in a localized manner 2 , but radiotherapy may fail since part of tumour cells are radiation resistant 3,4 .”
Wu, C., Zhuang, Y., Jiang, S., Tian, F., Teng, Y., Chen, X., Zheng, P.-Q., Liu, S., Zhou, J., Wu, J., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.005 · Cited by 63
Deng, S., Vlatkovic, T., Li, M., Zhan, T., Veldwijk, M. R., & Herskind, C. (2022) · Cancers · doi:10.3390/cancers14194874 · Cited by 62
Sharda, A., Rashid, M., Shah, S. G., Sharma, A. K., Singh, S. R., Gera, P. B., Krishna, C. M., & Gupta, S. (2020) · Clinical Epigenetics · doi:10.1186/s13148-019-0800-4 · Cited by 62
Nanomaterials for Combinational Radio–Immuno Oncotherapy
Wang, J., Li, Z., Wang, Z., Yu, Y., Li, D., Li, B., & Ding, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910676 · Cited by 62
Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
Ajmeera, D., & Ajumeera, R. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.12.013 · Cited by 67
“Radiation therapy involves changing the microenvironment of the tumor cells where the surrounding healthy cells may also undergo DNA damage leading to a new cancer incidence.(8) Similarly, surgical therapy is also a primary treatment modality for solid tumors; it strongly affects the survival of patients.”
Background
Metadata
- Authors
- Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J.
- Affiliations
- Institute of Cancer Research (GB)
- Corresponding author
- Barker, Holly E.
- Venue
- Nature Reviews Cancer
- Published
- 2015-06-24
- Volume
- 15
- Issue
- 7
- Pages
- 409-425
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4896389
- OpenAlex
- W1912124796
- Cited by
- 2,144
- References
- 200
- Citations by year
- 2026: 181 · 2025: 215 · 2024: 246 · 2023: 242 · 2022: 249 · 2021: 256 · 2020: 230 · 2019: 175 · 2018: 161 · 2017: 119 · 2016: 63 · 2015: 7
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-07-24)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research UK (C46 ⁄ A10588, C7224/A13407, A13407, 13407)
- National Institute for Health and Care Research (CL-2014-22-003)
- Rosetrees Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- tumor microenvironment, radioresistance (biology), radiotherapy, tumor stroma, tumor recurrence, vascular changes, immunological changes, combination therapy, molecularly targeted agents
- MeSH terms
- Animals, Fibroblasts, Humans, Immune Tolerance, Neoplasm Recurrence, Local, Neoplasms, Radiation Tolerance, Cell Hypoxia, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
